US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist

0.316
+0.004+1.41%

Close Aug 23 16:00 ET

0.315
-0.001-0.44%

Post 20:01 ET

20.68MMarket Cap-202P/E (TTM)

Lyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

30.57%598K

29.76%532K

14.31%1.56M

1,227.27%146K

51.53%544K

-12.76%458K

-12.39%410K

378.25%1.36M

-95.94%11K

2,464.29%359K

Operating revenue

30.57%598K

29.76%532K

14.31%1.56M

1,227.27%146K

51.53%544K

-12.76%458K

-12.39%410K

378.25%1.36M

-95.94%11K

2,464.29%359K

Cost of revenue

Gross profit

Operating expense

19.74%18.4M

35.73%24.06M

19.05%67.09M

20.02%16.62M

14.40%17.37M

2.97%15.37M

43.01%17.72M

28.37%56.35M

-0.42%13.85M

36.86%15.19M

Selling and administrative expenses

12.45%5.14M

13.48%5.82M

8.55%19.06M

-0.95%4.36M

-2.61%5M

10.60%4.57M

31.87%5.13M

23.58%17.56M

23.32%4.4M

27.85%5.14M

-General and administrative expense

12.45%5.14M

13.48%5.82M

8.55%19.06M

-0.95%4.36M

-2.61%5M

10.60%4.57M

31.87%5.13M

23.58%17.56M

23.32%4.4M

27.85%5.14M

Research and development costs

22.83%13.26M

44.79%18.24M

23.80%48.03M

29.79%12.27M

23.09%12.37M

0.06%10.8M

48.10%12.6M

30.66%38.8M

-8.62%9.45M

41.98%10.05M

Operating profit

-19.41%-17.81M

-35.87%-23.52M

-19.16%-65.53M

-19.06%-16.48M

-13.50%-16.83M

-3.55%-14.91M

-45.18%-17.31M

-26.08%-54.99M

-1.47%-13.84M

-33.80%-14.83M

Net non-operating interest income expense

-4.68%855K

1.31%1.09M

332.18%4.5M

43.41%1.34M

1,886.67%1.19M

2,538.24%897K

7,557.14%1.07M

920.59%1.04M

4,342.86%933K

130.77%60K

Non-operating interest income

-4.68%855K

1.31%1.09M

332.18%4.5M

43.41%1.34M

1,886.67%1.19M

2,538.24%897K

7,557.14%1.07M

920.59%1.04M

4,342.86%933K

130.77%60K

Other net income (expense)

-1,857.85%-31.17M

-20.97%-1.59M

-1.59M

-1.32M

Special income (charges)

-1,857.85%-31.17M

----

-20.97%-1.59M

--0

---1.59M

----

---1.32M

--0

-Less：Restructuring and merger&acquisition

--6.45M

----

--0

----

-Less:Impairment of capital assets

1,452.70%24.72M

----

20.97%1.59M

--0

--1.59M

----

--1.32M

--0

Income before tax

-208.34%-48.12M

-38.16%-22.44M

-13.31%-62.62M

-6.45%-15.14M

-5.89%-15.64M

-8.63%-15.61M

-36.35%-16.24M

-27.01%-55.27M

-4.44%-14.22M

-33.57%-14.77M

Income tax

0.00%12K

0.00%14K

353.85%59K

30.77%17K

16K

12K

14K

13K

Net income

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

-33.57%-14.77M

Net income continuous Operations

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

-33.57%-14.77M

Minority interest income

Net income attributable to the parent company

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

-33.57%-14.77M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-208.18%-48.13M

-38.12%-22.45M

-13.39%-62.68M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.26M

-27.04%-55.28M

-4.54%-14.24M

-33.57%-14.77M

Basic earnings per share

-105.56%-0.74

20.45%-0.35

31.15%-1.26

38.89%-0.22

32.50%-0.27

14.29%-0.36

52.17%-0.44

45.37%-1.83

65.71%-0.36

52.94%-0.4

Diluted earnings per share

-105.56%-0.74

20.45%-0.35

31.15%-1.26

38.89%-0.22

32.50%-0.27

14.29%-0.36

52.17%-0.44

45.37%-1.83

65.71%-0.36

52.94%-0.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	30.57%598K	29.76%532K	14.31%1.56M	1,227.27%146K	51.53%544K	-12.76%458K	-12.39%410K	378.25%1.36M	-95.94%11K	2,464.29%359K
Operating revenue	30.57%598K	29.76%532K	14.31%1.56M	1,227.27%146K	51.53%544K	-12.76%458K	-12.39%410K	378.25%1.36M	-95.94%11K	2,464.29%359K
Cost of revenue
Gross profit
Operating expense	19.74%18.4M	35.73%24.06M	19.05%67.09M	20.02%16.62M	14.40%17.37M	2.97%15.37M	43.01%17.72M	28.37%56.35M	-0.42%13.85M	36.86%15.19M
Selling and administrative expenses	12.45%5.14M	13.48%5.82M	8.55%19.06M	-0.95%4.36M	-2.61%5M	10.60%4.57M	31.87%5.13M	23.58%17.56M	23.32%4.4M	27.85%5.14M
-General and administrative expense	12.45%5.14M	13.48%5.82M	8.55%19.06M	-0.95%4.36M	-2.61%5M	10.60%4.57M	31.87%5.13M	23.58%17.56M	23.32%4.4M	27.85%5.14M
Research and development costs	22.83%13.26M	44.79%18.24M	23.80%48.03M	29.79%12.27M	23.09%12.37M	0.06%10.8M	48.10%12.6M	30.66%38.8M	-8.62%9.45M	41.98%10.05M
Operating profit	-19.41%-17.81M	-35.87%-23.52M	-19.16%-65.53M	-19.06%-16.48M	-13.50%-16.83M	-3.55%-14.91M	-45.18%-17.31M	-26.08%-54.99M	-1.47%-13.84M	-33.80%-14.83M
Net non-operating interest income expense	-4.68%855K	1.31%1.09M	332.18%4.5M	43.41%1.34M	1,886.67%1.19M	2,538.24%897K	7,557.14%1.07M	920.59%1.04M	4,342.86%933K	130.77%60K
Non-operating interest income	-4.68%855K	1.31%1.09M	332.18%4.5M	43.41%1.34M	1,886.67%1.19M	2,538.24%897K	7,557.14%1.07M	920.59%1.04M	4,342.86%933K	130.77%60K
Other net income (expense)	-1,857.85%-31.17M		-20.97%-1.59M	0		-1.59M		-1.32M
Special income (charges)	-1,857.85%-31.17M	----	-20.97%-1.59M	--0	--0	---1.59M	----	---1.32M	---1.32M	--0
-Less：Restructuring and merger&acquisition	--6.45M	----	----	----	----	--0	----	----	----	----
-Less:Impairment of capital assets	1,452.70%24.72M	----	20.97%1.59M	--0	--0	--1.59M	----	--1.32M	--1.32M	--0
Income before tax	-208.34%-48.12M	-38.16%-22.44M	-13.31%-62.62M	-6.45%-15.14M	-5.89%-15.64M	-8.63%-15.61M	-36.35%-16.24M	-27.01%-55.27M	-4.44%-14.22M	-33.57%-14.77M
Income tax	0.00%12K	0.00%14K	353.85%59K	30.77%17K	16K	12K	14K	13K	13K	0
Net income	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M	-33.57%-14.77M
Net income continuous Operations	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M	-33.57%-14.77M
Minority interest income
Net income attributable to the parent company	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M	-33.57%-14.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-208.18%-48.13M	-38.12%-22.45M	-13.39%-62.68M	-6.47%-15.16M	-5.99%-15.65M	-8.72%-15.62M	-36.47%-16.26M	-27.04%-55.28M	-4.54%-14.24M	-33.57%-14.77M
Basic earnings per share	-105.56%-0.74	20.45%-0.35	31.15%-1.26	38.89%-0.22	32.50%-0.27	14.29%-0.36	52.17%-0.44	45.37%-1.83	65.71%-0.36	52.94%-0.4
Diluted earnings per share	-105.56%-0.74	20.45%-0.35	31.15%-1.26	38.89%-0.22	32.50%-0.27	14.29%-0.36	52.17%-0.44	45.37%-1.83	65.71%-0.36	52.94%-0.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall